Benjamin A. Gartrell

4.3k total citations · 1 hit paper
74 papers, 1.4k citations indexed

About

Benjamin A. Gartrell is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Benjamin A. Gartrell has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 24 papers in Surgery. Recurrent topics in Benjamin A. Gartrell's work include Prostate Cancer Treatment and Research (27 papers), Bladder and Urothelial Cancer Treatments (23 papers) and Renal cell carcinoma treatment (19 papers). Benjamin A. Gartrell is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Bladder and Urothelial Cancer Treatments (23 papers) and Renal cell carcinoma treatment (19 papers). Benjamin A. Gartrell collaborates with scholars based in United States, United Kingdom and Canada. Benjamin A. Gartrell's co-authors include Fred Saad, Matthew D. Galsky, Guru Sonpavde, Kith Pradhan, Sanjay Goel, Amit Verma, Rafi Kabarriti, Ana Acuña-Villaorduña, Balázs Halmos and Andrew D. Racine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Benjamin A. Gartrell

71 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

2020 521 citations Vikas Mehta, Sanjay Goel et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin A. Gartrell United States	17	823	586	335	322	247	74	1.4k
Marwan Ghosn Lebanon	19	786 1.0×	458 0.8×	212 0.6×	102 0.3×	188 0.8×	122	1.4k
Valentina I. Petkov United States	16	442 0.5×	336 0.6×	196 0.6×	154 0.5×	203 0.8×	43	1.4k
Yüksel Ürün Türkiye	17	483 0.6×	334 0.6×	158 0.5×	85 0.3×	407 1.6×	136	1.1k
Deniz Can Güven Türkiye	20	851 1.0×	440 0.8×	265 0.8×	64 0.2×	213 0.9×	164	1.6k
Alice Indini Italy	23	999 1.2×	355 0.6×	371 1.1×	58 0.2×	243 1.0×	82	1.7k
Graham P. Collins United Kingdom	25	1.6k 2.0×	233 0.4×	355 1.1×	116 0.4×	80 0.3×	160	2.7k
Anil Londhe United States	18	304 0.4×	560 1.0×	213 0.6×	90 0.3×	367 1.5×	68	1.8k
Cristina Ivanescu United States	14	370 0.4×	659 1.1×	141 0.4×	79 0.2×	152 0.6×	71	1.0k
Hongjo Choi South Korea	20	843 1.0×	350 0.6×	179 0.5×	347 1.1×	573 2.3×	91	1.6k
Kenneth G. Nepple United States	25	317 0.4×	566 1.0×	346 1.0×	72 0.2×	1.1k 4.4×	109	2.1k

Countries citing papers authored by Benjamin A. Gartrell

Since Specialization

Citations

This map shows the geographic impact of Benjamin A. Gartrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Gartrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Gartrell more than expected).

Fields of papers citing papers by Benjamin A. Gartrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin A. Gartrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Gartrell. The network helps show where Benjamin A. Gartrell may publish in the future.

Co-authorship network of co-authors of Benjamin A. Gartrell

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin A. Gartrell. A scholar is included among the top collaborators of Benjamin A. Gartrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin A. Gartrell. Benjamin A. Gartrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ryan, Charles J., Arjun Gupta, Christopher J. Sweeney, et al.. (2025). Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial. European Urology Oncology.

Daneshmand, Siamak, Renata Zaucha, Nikhil Vasdev, et al.. (2024). MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS. Urologic Oncology Seminars and Original Investigations. 42. S58–S58. 1 indexed citations

Rais‐Bahrami, Soroush, Mark T. Fleming, Benjamin A. Gartrell, et al.. (2024). 18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study. Advances in Radiation Oncology. 9(9). 101571–101571. 1 indexed citations

Choudhury, Atish D., Glenn Heller, Melissa A. Reimers, et al.. (2024). A phase 2 trial of ADT interruption in patients responding exceptionally to AR-pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM/Alliance A032101).. Journal of Clinical Oncology. 42(16_suppl). TPS5118–TPS5118. 1 indexed citations

Inman, Brant A., Noah M. Hahn, Kelly Stratton, et al.. (2023). A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer. European Urology Oncology. 6(3). 313–320. 21 indexed citations

Grivas, Petros, Srikala S. Sridhar, Begoña P. Valderrama, et al.. (2023). 2374P A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC). Annals of Oncology. 34. S1209–S1210. 2 indexed citations

Luchtel, Rebecca A., Venkata R. Machha, Alexander Tischer, et al.. (2021). Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer. Proceedings of the National Academy of Sciences. 118(39). 52 indexed citations

Goel, Sanjay, et al.. (2021). Racial Diversity Among Histology of Renal Cell Carcinoma at an Urban Medical Center. Clinical Genitourinary Cancer. 19(3). e166–e170. 5 indexed citations

Mehta, Vikas, Sanjay Goel, Rafi Kabarriti, et al.. (2020). Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discovery. 10(7). 935–941. 521 indexed citations breakdown →

10.

Wang, Xiaoyang, Robert Lopez, Rebecca A. Luchtel, et al.. (2020). Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. Kidney International. 99(1). 75–85. 26 indexed citations

11.

Jia, Liwei, Maria I. Carlo, Hina Khan, et al.. (2019). Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases. Modern Pathology. 32(9). 1329–1343. 39 indexed citations

12.

Herrera, Diego Adrianzen, et al.. (2018). Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies. Frontiers in Oncology. 8. 137–137. 2 indexed citations

13.

Goel, Sanjay, et al.. (2018). Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population. Clinical Genitourinary Cancer. 17(2). 139–144. 10 indexed citations

14.

Gartrell, Benjamin A., et al.. (2017). Update of systemic immunotherapy for advanced urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 35(12). 678–686. 10 indexed citations

15.

Gartrell, Benjamin A., Robert E. Coleman, Eleni Efstathiou, et al.. (2015). Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options. European Urology. 68(5). 850–858. 69 indexed citations

16.

Gartrell, Benjamin A. & Fred Saad. (2014). Pathologic fracture in patients with metastatic prostate cancer. Current Opinion in Urology. 24(6). 595–600. 8 indexed citations

17.

Gartrell, Benjamin A., Jian Ying, Shanthi Sivendran, et al.. (2013). Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis. Targeted Oncology. 9(3). 195–204. 20 indexed citations

18.

Gartrell, Benjamin A., et al.. (2012). Emerging personalized approaches for the management of advanced urothelial carcinoma. Expert Review of Anticancer Therapy. 12(12). 1537–1543. 6 indexed citations

19.

Small, Alexander, Che-Kai Tsao, Erin Moshier, et al.. (2012). Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World Journal of Urology. 31(5). 1211–1217. 15 indexed citations

20.

Tsao, Che-Kai, Alexander Small, Erin Moshier, et al.. (2012). Trends in the Use of Cytoreductive Nephrectomy in the United States. Clinical Genitourinary Cancer. 10(3). 159–163. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact